262 related articles for article (PubMed ID: 32395526)
21. The prognostic value of multiorgan metastases in patients with non-small cell lung cancer and its variants: a SEER-based study.
Yang J; Zhang Y; Sun X; Gusdon AM; Song N; Chen L; Jiang G; Huang Y
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1835-1842. PubMed ID: 30003315
[TBL] [Abstract][Full Text] [Related]
22. Liver Metastases in Newly Diagnosed Gastric Cancer: A Population-Based Study from SEER.
Sun Z; Zheng H; Yu J; Huang W; Li T; Chen H; Hu Y; Zhao M; Liu H; Jiang Y; Li G
J Cancer; 2019; 10(13):2991-3005. PubMed ID: 31281476
[No Abstract] [Full Text] [Related]
23. Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients.
Song Q; Shang J; Zhang C; Zhang L; Wu X
J Cancer Res Clin Oncol; 2019 Mar; 145(3):737-746. PubMed ID: 30603904
[TBL] [Abstract][Full Text] [Related]
24. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
Barnholtz-Sloan JS; Sloan AE; Davis FG; Vigneau FD; Lai P; Sawaya RE
J Clin Oncol; 2004 Jul; 22(14):2865-72. PubMed ID: 15254054
[TBL] [Abstract][Full Text] [Related]
25. The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
Shou J; Zhang Q; Wang S; Zhang D
Prostate; 2018 May; 78(7):491-497. PubMed ID: 29436722
[TBL] [Abstract][Full Text] [Related]
26. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of liver metastases.
Horn SR; Stoltzfus KC; Lehrer EJ; Dawson LA; Tchelebi L; Gusani NJ; Sharma NK; Chen H; Trifiletti DM; Zaorsky NG
Cancer Epidemiol; 2020 Aug; 67():101760. PubMed ID: 32562887
[TBL] [Abstract][Full Text] [Related]
29. The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer.
Guo X; Zhang C; Guo Q; Xu Y; Feng G; Li L; Han X; Lu F; Ma Y; Wang X; Wang G
Cancer Manag Res; 2018; 10():1639-1646. PubMed ID: 29970963
[TBL] [Abstract][Full Text] [Related]
30. Bone metastases in newly diagnosed patients with thyroid cancer: A large population-based cohort study.
Zhang R; Zhang W; Wu C; Jia Q; Chai J; Meng Z; Zheng W; Tan J
Front Oncol; 2022; 12():955629. PubMed ID: 36033484
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of secondary solid tumor malignancies among patients with myeloma: A population-based study.
Barth P; Castillo JJ; Olszewski AJ
Cancer; 2019 Feb; 125(4):550-558. PubMed ID: 30452087
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of site-specific metastases in lung cancer: A population based study.
Li J; Zhu H; Sun L; Xu W; Wang X
J Cancer; 2019; 10(14):3079-3086. PubMed ID: 31289577
[No Abstract] [Full Text] [Related]
33. Patterns of Extrathoracic Metastases in Different Histological Types of Lung Cancer.
Wang X; Wang Z; Pan J; Lu ZY; Xu D; Zhang HJ; Wang SH; Huang DY; Chen XF
Front Oncol; 2020; 10():715. PubMed ID: 32509574
[TBL] [Abstract][Full Text] [Related]
34. Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study.
Yang Y; Tu Z; Ye C; Cai H; Yang S; Chen X; Tu J
BMC Surg; 2021 Jan; 21(1):59. PubMed ID: 33485332
[TBL] [Abstract][Full Text] [Related]
35. Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
Hong S; Youk T; Lee SJ; Kim KM; Vajdic CM
PLoS One; 2020; 15(7):e0234927. PubMed ID: 32678818
[TBL] [Abstract][Full Text] [Related]
36. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
37. Population-based evaluation of the risk factors and prognosis among renal cell carcinoma patients with initially diagnosed lung metastases.
Zhang Z; Liang C; Hou B; Zhou L
Actas Urol Esp (Engl Ed); 2021 Sep; 45(7):498-506. PubMed ID: 34332926
[TBL] [Abstract][Full Text] [Related]
38. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site.
Xu P; Wang J; Abudurexiti M; Jin S; Wu J; Shen Y; Ye D
Front Oncol; 2019; 9():1495. PubMed ID: 31998648
[No Abstract] [Full Text] [Related]
40. Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database.
Campos-Balea B; de Castro Carpeño J; Massutí B; Vicente-Baz D; Pérez Parente D; Ruiz-Gracia P; Crama L; Cobo Dols M
Thorac Cancer; 2020 Nov; 11(11):3357-3364. PubMed ID: 32986309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
